Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity.
作者信息
Jones R N
机构信息
Clinical Microbiology Institute, Tualatin, Oregon 97062.
出版信息
Antimicrob Agents Chemother. 1989 Sep;33(9):1652-3. doi: 10.1128/AAC.33.9.1652.
Abstract
摘要
相似文献
1
Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity.降低阳离子补充建议（美国国家临床实验室标准委员会）对达托霉素抗葡萄球菌活性的影响。
Antimicrob Agents Chemother. 1989 Sep;33(9):1652-3. doi: 10.1128/AAC.33.9.1652.
2
Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.通过时间杀菌动力学研究确定人血清对达托霉素和万古霉素针对葡萄球菌和肠球菌分离株的杀菌活性的影响。
Diagn Microbiol Infect Dis. 1990 May-Jun;13(3):245-52. doi: 10.1016/0732-8893(90)90067-6.
3
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.通过杀菌动力学研究确定LY146032与甲氧西林、头孢唑林、头孢孟多、头孢呋辛、环丙沙星和万古霉素对葡萄球菌的活性比较。
Antimicrob Agents Chemother. 1987 Aug;31(8):1210-5. doi: 10.1128/AAC.31.8.1210.
4
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.达托霉素和替考拉宁对溶血葡萄球菌和表皮葡萄球菌的活性，包括药敏试验建议的评估。
Antimicrob Agents Chemother. 1989 Apr;33(4):585-8. doi: 10.1128/AAC.33.4.585.
5
Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci.
Eur J Clin Microbiol. 1987 Apr;6(2):186-8. doi: 10.1007/BF02018206.
6
In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.达托霉素和替加环素对骨髓移植受者凝固酶阴性葡萄球菌血培养分离株的体外活性
Eur J Haematol. 2007 Nov;79(5):405-9. doi: 10.1111/j.1600-0609.2007.00945.x. Epub 2007 Aug 20.
7
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.LY146032（达托霉素）对革兰氏阳性球菌的体外活性比较
Eur J Clin Microbiol. 1987 Feb;6(1):96-9. doi: 10.1007/BF02097210.
8
In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin).环脂肽LY 146032（达托霉素）的体外评估
S Afr Med J. 1988 Jul 2;74(1):16-8.
9
The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci.培养条件对LY146032抗葡萄球菌和链球菌活性的影响。
J Antimicrob Chemother. 1987 Aug;20(2):213-21. doi: 10.1093/jac/20.2.213.
10
Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.
J Chemother. 1993 Jun;5(3):151-4. doi: 10.1080/1120009x.1993.11739224.
引用本文的文献
1
Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001.2000 - 2001年在美国进行的一项基线研究，以确定达托霉素对革兰氏阳性病原体的体外活性。
Antimicrob Agents Chemother. 2003 May;47(5):1689-93. doi: 10.1128/AAC.47.5.1689-1693.2003.
2
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.达托霉素、万古霉素、奎奴普丁-达福普汀、利奈唑胺及其他五种抗菌药物对307株革兰氏阳性厌氧菌和31株棒状杆菌临床分离株的体外活性。
Antimicrob Agents Chemother. 2003 Jan;47(1):337-41. doi: 10.1128/AAC.47.1.337-341.2003.
3
In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.新型糖肽衍生物LY333328的体外活性及抗菌谱
Antimicrob Agents Chemother. 1997 Feb;41(2):488-93. doi: 10.1128/AAC.41.2.488.
4
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.万古霉素对螺旋体伯氏疏螺旋体的体外活性。
Antimicrob Agents Chemother. 1993 May;37(5):1115-21. doi: 10.1128/AAC.37.5.1115.
本文引用的文献
1
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.新型环脂肽抗生素A21978C1的体外活性及作用机制
Antimicrob Agents Chemother. 1985 Mar;27(3):357-62. doi: 10.1128/AAC.27.3.357.
2
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.阳离子补充剂对奈替米星体外及体内抗铜绿假单胞菌活性的影响。
Antimicrob Agents Chemother. 1987 Oct;31(10):1514-8. doi: 10.1128/AAC.31.10.1514.
3
Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations.脂肽抗生素LY146032的抗菌活性与谱，包括药敏试验建议。
Antimicrob Agents Chemother. 1987 Apr;31(4):625-9. doi: 10.1128/AAC.31.4.625.
4
Effect of calcium on in vitro activity of LY146032 against Clostridium difficile.钙对LY146032体外抗艰难梭菌活性的影响。
Antimicrob Agents Chemother. 1987 Mar;31(3):461-2. doi: 10.1128/AAC.31.3.461.
5
Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes.荧光表明脂肽抗生素LY146032与磷脂膜之间存在钙依赖性相互作用。
Biochemistry. 1988 Jun 28;27(13):4639-45. doi: 10.1021/bi00413a009.
6
Nomenclature of LY146032.LY146032的命名法。
J Antimicrob Chemother. 1988 Jan;21(1):133. doi: 10.1093/jac/21.1.133.
7
The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci.培养条件对LY146032抗葡萄球菌和链球菌活性的影响。
J Antimicrob Chemother. 1987 Aug;20(2):213-21. doi: 10.1093/jac/20.2.213.
8
Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.LY146032对革兰氏阳性菌肽聚糖生物合成的抑制作用。
Antimicrob Agents Chemother. 1987 Jul;31(7):1093-9. doi: 10.1128/AAC.31.7.1093.
Zotero 插件